TMCnet News
Vor Bio to Participate in Upcoming Investor ConferencesCAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Piper Sandler 34th Annual Healthcare Conference 5th Annual Evercore ISI HealthCONx Virtual Conference The JMP Securities Hematology and Oncology Virtual Summit A live webcast and archived replay of the presentation and fireside chats will be available o the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/ About Vor Bio Contact: Media & Investors |